GINA AMIANO: Open Payments
NPI 1497122683 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 28 payments from 6 companies in 2025. Trend: 2023 $899 · 2024 $351 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $253 |
| ABBVIE INC. | 18 | $171 |
| Vanda Pharmaceuticals Inc. | 3 | $116 |
| PFIZER INC. | 2 | $37 |
| Exact Sciences Corporation | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: AIRSUPRA, FANAPT, UBRELVY, VRAYLAR, NURTEC ODT, QULIPTA, Cologuard Collection Kit, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
